{{no footnotes|date=June 2010}}

{{Drugbox
| Watchedfields = changed
| verifiedrevid = 461096712
| IUPAC_name = 3-Ethyl-5-phenyl-imidazolidine-2,4-dione
| image = Ethotoin.svg
| alt = Skeletal formula of ethotoin
| width = 105

<!--Clinical data-->
| tradename =
| Drugs.com = {{drugs.com|CDI|ethotoin}}
| MedlinePlus = a682022
| pregnancy_category = C
| legal_status =  
| routes_of_administration = [[Oral administration|By mouth]] ([[Tablet (pharmacy)|tablets]])

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life = 3–9 hours

<!--Identifiers-->
| IUPHAR_ligand = 7183
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 86-35-1
| ATC_prefix = N03
| ATC_suffix = AB01
| ATC_supplemental =  
| PubChem = 3292
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00754
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3176
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 46QG38NC4U
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00708
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 4888
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1095

<!--Chemical data-->
| C=11 | H=12 | N=2 | O=2
| molecular_weight = 204.225 g/mol
| smiles = O=C2NC(c1ccccc1)C(=O)N2CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H12N2O2/c1-2-13-10(14)9(12-11(13)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H,12,15)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SZQIFWWUIBRPBZ-UHFFFAOYSA-N
}}

'''Ethotoin''' (marketed as '''Peganone''' by [[Ovation Pharma|Ovation]]) is an [[anticonvulsant]] drug used in the treatment of [[epilepsy]]. It is a [[hydantoin]], similar to [[phenytoin]]. 
==Mechanism of action==
Similar to phenytoin.

==Approval history==
*'''1957''' Peganone was granted [[Food and Drug Administration]] (FDA) approval to [[Abbott Laboratories]] for treatment of grand mal (tonic clonic) and partial complex (psychomotor) seizures.
*'''2003''' Peganone was acquired from Abbott Laboratories by Ovation Pharmaceuticals (specialty pharmaceutical company who acquire underpromoted branded pharmaceutical products).

==Indications and usage==
Ethotoin is indicated for tonic-clonic and partial complex seizures.

==Dosing==
Ethotoin is available in 250&nbsp;mg tablets. It is taken orally in 4 to 6 divided doses per day, preferably after food.

==Side effects==
[[Ataxia]], visual disturbances, rash and [[Gastrointestinal tract|gastrointestinal]] problems.

==Chemistry==
Ethotoin, 3-ethyl-5-phenylimidazolidine-2,4-dione, is synthesized by the reaction of benzaldehyde oxynitrile, with [[urea]] or ammonium hydrocarbonate, which forms an intermediate urea derivative which on acidic conditions cyclizes to 5-phenylhydantoin. Alkylation of this product using ethyliodide leads to the formation
of ethotoin.

[[File:Ethotoin synthesis.png|thumb|center|800px|A. Pinner, Chem. Ber., 21, 2324 (1888); W.J. Close, {{US Patent|2793157}} (1946).]]
{{clear left}}

==References==
* {{cite journal |vauthors=Schwade ED, Richards RK, Everett GM |title=Peganone, a new antiepileptic drug |journal=Dis Nerv Syst |volume=17 |issue=5 |pages=155–8 |date=May 1956 |pmid=13317788 }}
* {{cite book |editor=Shorvon, S.D. |editor2=Fish, David R. |editor3=Perucca, Emilio |editor4=Dodson, W. Edwin |title=The Treatment of Epilepsy |publisher=Blackwell Publishing |year=2004 |isbn=0-632-06046-8 }}
* [http://www.drugs.com/pdr/ETHOTOIN.html Drugs.com: Ethotoin]
* [http://ovationpharmaceuticals.com/images/products/pdf/peganone_pi.pdf PEGANONE 250 mg Ethotoin Tablets, USP] (PDF)

==External links==
* [http://www.ovationpharma.com/ Ovation Pharmaceuticals]

{{Anticonvulsants}}

[[Category:Anticonvulsants]]
[[Category:Hydantoins]]